A Multi-center, Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
Latest Information Update: 13 Jan 2022
At a glance
- Drugs Amlodipine/olmesartan-medoxomil/rosuvastatin (Primary) ; Amlodipine/rosuvastatin (Primary) ; Olmesartan medoxomil/amlodipine (Primary) ; Olmesartan medoxomil/rosuvastatin (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 28 Feb 2019 Status changed from recruiting to completed, according to Daewoong Pharmaceutical media release.
- 07 Jan 2017 New trial record